Clinical trial / 2014
Oral cholecalciferol supplementation reduced pain scores in women with fibromyalgia and low vitamin D.
Thirty women with fibromyalgia and serum calcifediol below 32 ng/mL were randomized to oral cholecalciferol or placebo for 20 weeks, targeting levels of 32 to 48 ng/mL. The supplemented group demonstrated a marked reduction in pain on the visual analog scale across time points compared to control. Pain reductions correlated with improvements on the physical role functioning scale.
- Study type
- Randomized controlled trial
- Who was studied
- 30 women with fibromyalgia and low calcifediol
- What was measured
- Pain severity and physical functioning
THE PAPER
Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial.
Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, Hahne J, Friedrich M. Pain, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.